Skip to main content
SpringerLink
Log in

Quetiapin zur Behandlung der Borderline-Persönlichkeitsstörung?

Erste randomisierte kontrollierte Studie veröffentlicht

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Lieb K et al. Brit J Psychiatry 2010; 196: 4–12

    Article  Google Scholar 

Literatur

  • Black DW, Zanarini MC, Romine A et al. Comparison of Low and Moderate Dosages of Extended-Release Quetiapine in Borderline Personality Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Am J Psychiatry (in press); doi: 10.1176/appi.ajp.2014.13101348

Download references

Author information

Authors and Affiliations

  1. Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Mainz, Mainz, Deutschland

    Klaus Lieb

Authors
  1. Klaus Lieb
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Klaus Lieb.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lieb, K. Quetiapin zur Behandlung der Borderline-Persönlichkeitsstörung?. InFo Neurologie 16, 35 (2014). https://doi.org/10.1007/s15005-014-0978-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-014-0978-0

Search

Navigation